Polar Capital Holdings’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-67,188	Closed	-$23.2M	–	277
2024 Q1	$23.2M	Buy	67,188 +14,462	+27%	+$4.76M	0.12%	138
2023 Q4	$17M	Buy	52,726 +11,151	+27%	+$3.5M	0.1%	149
2023 Q3	$14.9M	Buy	41,575 +16,824	+68%	+$6.49M	0.11%	158
2023 Q2	$9.38M	Sell	24,751 -123,156	-83%	-$50.1M	0.06%	202
2023 Q1	$70.9M	Buy	147,907 +37,863	+34%	+$17.7M	0.52%	63
2022 Q4	$46.3M	Buy	110,044 +6,390	+6%	+$2.58M	0.37%	87
2022 Q3	$43.2K	Sell	103,654 -11,405	-10%	-$5.69M	0.28%	85
2022 Q2	$57K	Buy	115,059 +3,263	+3%	+$1.7M	0.33%	73
2022 Q1	$63K	Buy	111,796 +7,900	+8%	+$4.76M	0.29%	84
2021 Q4	$78.5K	Buy	103,896 +1,950	+2%	+$1.46M	0.32%	78
2021 Q3	$76K	Sell	101,946 -95,713	-48%	-$71.7M	0.33%	76
2021 Q2	$127K	Buy	197,659 +9,765	+5%	+$5.94M	0.55%	36
2021 Q1	$107M	Buy	187,894 +24,900	+15%	+$14.7M	0.67%	41
2020 Q4	$95M	Buy	+162,994	New	+$92.8M	0.62%	43